DI
LSTA icon

Deeter Investments’s Lisata Therapeutics LSTA Stock Holding History

Deeter Investments’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$404K Sell
118,871
-245,608
-67% -$874K 0.06% 92
2026
Q1 		$1.83M Buy
+364,479
New +$1.5M 0.21% 68

Other funds holding LSTA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
YCM
Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
GS
GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return

Deeter Investments's LSTA Position: Q2 2026 in Review

Deeter Investments reduced its Lisata Therapeutics (LSTA) stake by 67% in Q2 2026, selling an estimated $874K and leaving 118,871 shares worth $404K. The position accounts for 0.06% of the portfolio, ranked #92.

Deeter Investments first reported a position in LSTA in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.83M in Q1 2026. 32 funds tracked by Wall St. Rank hold LSTA as of Q2 2026.

  • Deeter Investments held 118,871 shares of Lisata Therapeutics worth $404K as of Q2 2026.
  • Deeter Investments sold 245,608 Lisata Therapeutics shares in Q2 2026, an estimated $874K.
  • Lisata Therapeutics made up 0.06% of Deeter Investments's portfolio in Q2 2026, its #92 holding.
  • Deeter Investments first reported a position in Lisata Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Deeter Investments's Lisata Therapeutics position peaked at $1.83M in Q1 2026.
  • 32 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q2 2026.

Based on Deeter Investments's 13F filing for Q2 2026, filed 8 Oct 2026.